Ketamine

Ketamine

Form: Intravenous (IV) and Intramuscular (IM) Injection

Strength: 10 mg/mL, 50 mg/mL, 100 mg/mL

Reference Brands: Ketalar(US)

Category: Critical Care

Ketamine is a versatile dissociative anesthetic used for anesthesia induction, procedural sedation, pain management, and treatment-resistant depression. It is available in injectable strengths of 10 mg/mL, 50 mg/mL, and 100 mg/mL, supplied in vials, ampoules, or pre-filled syringes. In the US, Ketalar (Pfizer) and generics from Hikma and Fresenius are widely used. In the EU, Ketamine Molteni, Ketanest S, and B. Braun formulations are common. With both anesthetic and analgesic properties, ketamine is essential for surgery, emergency care, and intensive care units. It is frequently procured via pharma B2B platforms by hospitals, clinics, and critical care facilities.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.